A Conversation Around Addressing Organizational & Leadership Fears and Taking Facilities Tobacco-Free Original Air Date: Friday, January 28, 12:0 p.m. – 1:30 p.m. ET Smoke-free environments in mental health and ...
In the U.S., 34% of adults with mental health challenges who use tobacco identify as Black, and 32% identify as Hispanic/Latinx. Understanding this relationship between mental health and substance use ...
Integrating Racial Equity and Mental Wellbeing in Tobacco Cessation: Tobacco and Mental Wellbeing Masterclass Workshop Original Air Date: February 7th 1:30 - 3:30 pm ET In the U.S., 34% of ...
Description On February 10, 2022, the U.S. Food and Drug Administration's (FDA) Center for Tobacco Products (CTP) is holding a public webinar titled “FDA’s Rulemaking Process and Planned Tobacco Product ...
Varenicline, an FDA-approved prescription smoking cessation aid, is an effective evidence-based treatment for reducing tobacco use among individuals with mental health and substance use challenges. Join the National Behavioral Health ...
National, state, and local-level data sources are essential to address tobacco-related disparities among individuals with mental health and substance use challenges. But, knowing how to find, understand and apply these ...
